• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Auto Injector Market Size & Share, 2018-2023 | Global Industry Report

Auto-Injector Market Size Analysis, Segmentation, Industry Outlook and Forecasts, 2018 - 2023

Report ID: MN17618584  |  Published: October 2018  |  No of Pages: 124
Format: Electronic (PDF)  |  Industry: Medical Devices  |  Publisher: GEN CONSULTING

Global auto-injector market is anticipated to grow at a significant CAGR during the forecast period. Auto injectors are alternative to manual syringe injections for subcutaneous administration of drugs. The devices allow the patient to self-inject for diagnosis. Patients with a chronic history of autoimmune disorders and multiple scelerosis are known to have using auto injectors. Technically, auto injector devices are auto injector pens having a push switch at the top with a closure.

Auto injector market is driven by rise in prevalence of targeted therapies such as multiple scelerosis, rheumatoid arthritis and higher incidence of anaphylaxis. In addition, availability of various auto-injector devices for better route of drug administration is supplementing the market growth. High risks associated with conventional syringes coupled with discontinuation of drugs also propels the market growth. Patient compliance, demand for biologics, rise in number of diabetic patients and growth in cancer cases are more likely to enlarge the market demand. However, regulatory approvals, injuries, infections and mortality rate hinder the market growth during the forecast period.

Product segmentation for auto injector market comprises fillable and prefilled auto injectors. By technology, the market entails automated and manual auto injectors. By design, the market is bifurcated into standardized and customized. Usability segment for auto-injector industry comprises reusable and disposable auto injectors.

Geographical segmentation for the market comprises North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America dominates the global market owing to presence of medical infrastructure, FDA approvals and rise in prevalence of anaphylaxis. Increasing prevalence of autoimmune and chronic disease in US are triggering the regional market growth.

Asia-Pacific regions are rising at a higher CAGR due to rising incidences of autoimmune disorders, availability of medical infrastructure and significance of technological developments in the region. The key players profiled in auto-injector market report are Amgen, Abbvie, Biogen, Eli Lilly, Merck, J&J, Novartis, Bayer, Ypsomed, Becton, Dickinson & Company, Owen Mumford and Haselmeier.

Market Segment:

Report contents include
• Analysis of the auto-injector market including revenues, future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Profiles on auto-injector including products, sales/revenues, and market position
• Market structure, market drivers and restraints.

Key regions
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Key Vendors
• request free sample to get a complete list of companies

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available